| 000 | 01135 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513131809.0 | ||
| 264 | 0 | _c19971218 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0032-5481 | ||
| 024 | 7 |
_a10.3810/pgm.1997.11.356 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaxon, D P | |
| 245 | 0 | 0 |
_aThrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction? _h[electronic resource] |
| 260 |
_bPostgraduate medicine _cNov 1997 |
||
| 300 |
_a97-8, 103-4, 107-8 passim p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tPostgraduate medicine _gvol. 102 _gno. 5 _gp. 97-8, 103-4, 107-8 passim |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3810/pgm.1997.11.356 _zAvailable from publisher's website |
| 999 |
_c9355126 _d9355126 |
||